152 related articles for article (PubMed ID: 38191717)
61. Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma.
Yang Y; Cao JZ; Lan SM; Wu JX; Wu T; Zhu SY; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Xu LM; Yuan ZY; Qi SN; Li YX
JAMA Oncol; 2017 Jan; 3(1):83-91. PubMed ID: 27893001
[TBL] [Abstract][Full Text] [Related]
62. A controlling nutritional status score is an independent predictor for patients with newly diagnosed nasal-type extranodal NK/T-cell lymphoma based on asparaginase-containing regimens.
Wu W; Ren K; Chen X; Li N; Zhou H; Jiang M; Yu Y; Zou L
Cancer Med; 2023 Apr; 12(8):9439-9448. PubMed ID: 36866811
[TBL] [Abstract][Full Text] [Related]
63. Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities.
Kim WY; Nam SJ; Kim S; Kim TM; Heo DS; Kim CW; Jeon YK
Leuk Lymphoma; 2015 Jun; 56(6):1778-86. PubMed ID: 25288491
[TBL] [Abstract][Full Text] [Related]
64. [Characteristics and prognostic value of peripheral blood T lymphocyte subsets in patients with severe influenza].
Geng TR; Han Y; Qiu ZF; Du TK; Jiang W; Shi JH; Qin T; Fan HW; Li TS
Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):200-206. PubMed ID: 32146746
[No Abstract] [Full Text] [Related]
65. Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG).
Qi SN; Xu LM; Yuan ZY; Wu T; Zhu SY; Shi M; Su H; Wang Y; He X; Zhang LL; Wu G; Qu BL; Qian LT; Hou XR; Zhang FQ; Zhang YJ; Zhu Y; Cao JZ; Lan SM; Wu JX; Yang Y; Li YX
Leuk Lymphoma; 2019 Nov; 60(11):2669-2678. PubMed ID: 31060406
[TBL] [Abstract][Full Text] [Related]
66. Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study.
Li YJ; Yi PY; Li JW; Liu XL; Tang T; Zhang PY; Jiang WQ
Chin J Cancer; 2017 Jul; 36(1):62. PubMed ID: 28756771
[TBL] [Abstract][Full Text] [Related]
67. Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.
Yan Y; Wang X; Liu C; Jia J
BMC Pulm Med; 2022 Apr; 22(1):166. PubMed ID: 35484541
[TBL] [Abstract][Full Text] [Related]
68. Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring.
Qi F; Cao Z; Chen B; Chai Y; Lin J; Ye J; Wei Y; Liu H; Han-Zhang H; Mao X; Feng X; Dong M
Blood Adv; 2021 Jun; 5(11):2505-2514. PubMed ID: 34047776
[TBL] [Abstract][Full Text] [Related]
69. Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma.
Liu Z; Sarathkumara YD; Chan JKC; Kwong YL; Lam TH; Ip DKM; Chiu BC; Xu J; Su YC; Proietti C; Cooper MM; Yu KJ; Bassig B; Liang R; Hu W; Ji BT; Coghill AE; Pfeiffer RM; Hildesheim A; Rothman N; Doolan DL; Lan Q
Sci Rep; 2021 Dec; 11(1):23664. PubMed ID: 34880297
[TBL] [Abstract][Full Text] [Related]
70. The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project.
Mitrovic Z; Perry AM; Suzumiya J; Armitage JO; Au WY; Coiffier B; Holte H; Jaffe ES; Monserrat E; Rajan SK; Savage KJ; Tobinai K; Vose JM; Weisenburger DD
Am J Hematol; 2012 Aug; 87(8):790-4. PubMed ID: 22488678
[TBL] [Abstract][Full Text] [Related]
71. [The Value of T Cell subsets and Cytokine Levels Changes in the Clinical Diagnosis, Treatment and Prognosis Evaluation of Multiple Myeloma].
Yan ZM; Liu YQ; Huang ZF; Liang Y; Lin J; Shen JZ; Chen XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1791-1796. PubMed ID: 36476905
[TBL] [Abstract][Full Text] [Related]
72. [Influence of Pre-treatment Lymphocyte/Monocyte Ratio and Neutrophil/Lymphocyte Ratio on the Prognosis of Patients with Extranodal NK/T-Cell Lymphoma].
Deng XY; Wang YY; Dang QQ; Liang TS; Zheng YJ; Yang DK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):707-713. PubMed ID: 37356930
[TBL] [Abstract][Full Text] [Related]
73. A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.
Lim JQ; Huang D; Chan JY; Laurensia Y; Wong EKY; Cheah DMZ; Chia BKH; Chuang WY; Kuo MC; Su YJ; Cai QQ; Feng Y; Rao H; Feng LN; Wei PP; Chen JR; Han BW; Lin GW; Cai J; Fang Y; Tan J; Hong H; Liu Y; Zhang F; Li W; Poon MLM; Ng SB; Jeyasekharan A; Ha JCH; Khoo LP; Chin ST; Pang WL; Kee R; Cheng CL; Grigoropoulos NF; Tang T; Tao M; Farid M; Puan KJ; Xiong J; Zhao WL; Khor CC; Hwang W; Kim WS; Campo E; Tan P; Teh BT; Chng WJ; Rötzschke O; Tousseyn T; Huang HQ; Rozen S; Lim ST; Shih LY; Bei JX; Ong CK
Am J Hematol; 2022 Sep; 97(9):1159-1169. PubMed ID: 35726449
[TBL] [Abstract][Full Text] [Related]
74. Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.
Schmitt C; Sako N; Bagot M; Huang Y; Gaulard P; Bensussan A
J Biomed Biotechnol; 2011; 2011():790871. PubMed ID: 21541194
[TBL] [Abstract][Full Text] [Related]
75. Nomograms based on SUVmax of
Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
[TBL] [Abstract][Full Text] [Related]
76. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.
Zhang H; Li ZL; Ye SB; Ouyang LY; Chen YS; He J; Huang HQ; Zeng YX; Zhang XS; Li J
Cancer Immunol Immunother; 2015 Dec; 64(12):1587-99. PubMed ID: 26497849
[TBL] [Abstract][Full Text] [Related]
77. Elevated serum IL-6 and total IgEAb are associated with poor survival in natural killer/T-cell lymphoma.
Hui Y; Gao Y; Li J; Kong Q; Duan Y; Liu H; Liu F; Sang H
Ann Hematol; 2024 Apr; 103(4):1285-1292. PubMed ID: 38095656
[TBL] [Abstract][Full Text] [Related]
78. The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma.
Li N; Jiang M; Wu WC; Zou LQ
Ann Hematol; 2022 Jul; 101(7):1545-1556. PubMed ID: 35635579
[TBL] [Abstract][Full Text] [Related]
79. The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States.
Vargo JA; Patel A; Glaser SM; Balasubramani GK; Farah RJ; Marks SM; Beriwal S
Cancer; 2017 Aug; 123(16):3176-3185. PubMed ID: 28380259
[TBL] [Abstract][Full Text] [Related]
80. Treatment and Prognosis of Newly Diagnosed Advanced-Stage Extranodal Natural Killer/T-Cell Lymphoma: A Single-Center Real-World Study across Two Decades.
Wei YC; Qi F; Chen B; Zhang CG; Fang H; Zhang D; Qi SN; Chai Y; Li YX; Dong M
Chemotherapy; 2024; 69(2):108-121. PubMed ID: 37984344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
